Vivo?Efficacy of?Blood stable?Thiobenzamides?

Where this opportunity stands

Every notice posted under solicitation 75N98026Q01123 in this department, oldest first.

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

• Decide bid or no bid before the response deadline.
• Look at the past winners for likely competitors and teaming partners.
• Follow the opportunity to hear about amendments and the award.

What the notice says

Who won similar work

3 award notices on SAM.gov in the last 24 months. Matched by: Same agency (National Institutes of Health), same product/service code (PSC) 6505.

Single-winner award sizes (3): middle half $82K to $470K, median $137K; range $28K to $804K.

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.

• Dec 20, 202410X GENOMICS, INC.$28K65--Xenium Add On KitMateriality: <0.01% of $TXG revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $28K award ÷ $616.9M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Dec 2, 2024VECTOR BIOMED INC.$804KServices for the Production and Stability Testing of Clinical Grade Lentiviral VectorNo listed company matched (Materiality N/A)
• Nov 19, 2024PACIFIC BIOSCIENCES OF CALIFORNIA, INC$137K65--Revio SPRQ reagent kitMateriality: 0.09% of $PACB revenue (Low)Calculated as Award Amount divided by the company's trailing twelve-month revenue (SEC 10-Q). Here: $137K award ÷ $159.3M revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 3 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.